Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
Speak to your health care provider before stopping GLP1-RAs to discuss when to stop and how to manage your condition
Key distinctions in the evidence: Tesamorelin: licensed in the US, narrowly indicated, established in HIV-related lipodystrophy, with effects that reverse on stopping treatment Retatrutide: investigational, broader metabolic potential, not yet approved anywhere globally Patients and clinicians should interpret early-phase data for retatrutide with appropriate caution
Listen to your gut
Search intent This page answers a specific Provider Comparisons question rather than a generic overview
For the best outcomes, its important to follow your healthcare providers guidance and maintain a healthy lifestyle, including regular exercise and a balanced diet
Ralph DeFronzo is used without his permission
US$ 22.35
US$ 21.57
US$ 29.73
US$ 24.22
US$ 29.29
US$ 21.05
US$ 21.84
US$ 25.21
